Our monthly newsletters feature our most recent event & educational opportunities, with additional highlights including popular blog posts, podcast episodes, featured faculty members, and scientific spotlights.
Harmful Medications Prescribed to Nearly 25% of Patients with HFrEF
REDUCE-IT Trial Presents Updated Findings
ACC & AHA will release comprehensive guidelines for primary CVD prevention at ACC conference
View the latest cardiometabolic-related guidelines and clinical pearls, with specific spotlights on diabetes management; hypertension and heart failure; obesity & lifestyle management in CVD; and dyslipidemia, atherosclerosis, and CVD risk reduction.
If you have any issues submitting this form, please contact the CMHC at 877-571-4700.